1)Jemal A, Siegel R, Xu J, et al:Cancer statistics, 2010. CA Cancer J Clin. 60:277-300, 2010
2)Martella L, Bertozzi S, Londero AP, et al:Surgery for liver metastases from gastric cancer:a meta-analysis of observational studies. Medicine(Baltimore)94:e1113, 2015
3)Qiu JL, Deng MG, Li W, et al:Hepatic resection for synchronous hepatic metastasis from gastric cancer. Eur J Surg Oncol 39:694-700, 2013
4)D'Angelica M, Gonen M, Brennan MF, et al:Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240:808-816, 2004
5)Saiura A, Umekita N, Inoue S, et al:Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 49:1062-1065, 2022
6)Fujitani K, Yang HK, Mizusawa J, et al:Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor(REGATTA):a phase 3, randomised controlled trial. Lancet Oncol 17:309-318, 2016
7)Romano F, Garancini M, Uggeri F, et al:Surgical treatment of liver metastases of gastric cancer:state of the art. World J Surg Oncol 10:157, 2012
8)Takemura N, Saiura A, Koga R, et al:Long-term outcomes after surgical resection for gastric cancer liver metastasis:an analysis of 64 macroscopically complete resections. Langenbecks Arch Surg 397:951-957, 2012
9)Ambiru S, Miyazaki M, Ito H, et al:Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181:279-283, 2001
10)Kinoshita T, Kinoshita T, Saiura A, et al:Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg 102:102-107, 2015
11)Okano K, Maeba T, Ishimura K, et al:Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235:86-91, 2021
12)Ochiai T, Sasako M, Mizuno S, et al:Hepatic resection for metastatic tumours from gastric cancer:analysis of prognostic factors. Br J Surg 81:1175-1178, 1994
13)Imamura H, Matsuyama Y, Shimada R, et al:A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96:3178-3184, 2001
14)Fujii K, Fujioka S, Kato K, et al:Resection of liver metastasis from gastric adenocarcinoma. Hepatogastroenterology 48:368-371, 2001
15)Sakamoto Y, Sano T, Shimada K, et al:Favorable Indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 95:534-539, 2007
16)Koga R, Yamamoto J, Ohyama S, et al:Liver resection for metastatic gastric cancer:experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol 37:836-842, 2007
17)Morise Z, Sugioka A, Hoshimoto S, et al:The role of hepatectomy for patients with liver metastases of gastric cancer. Hepatogastroenterology 55:1238-1241, 2008
18)Ueda K, Iwahashi M, Nakamori M, et al:Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Langenbecks Arch Surg 394:647-653, 2009
19)Aizawa M, Nashimoto A, Yabusaki H, et al:Clinical benefit of surgical management for gastric cancer with synchronous liver metastasis. Hepatogastroenterology 61:1439-1445, 2014
20)Fukami Y, Kaneoka Y, Maeda A, et al:Adjuvant hepatic artery infusion chemotherapy after hemihepatectomy for gastric cancer liver metastases. Int J Surg 46:79-84, 2017
21)Kawahara K, Makino H, Kametaka H, et al:Outcomes of surgical resection for gastric cancer liver metastases:a retrospective analysis. World J Surg Oncol 18:41, 2020
22)Komeda K, Hayashi M, Kubo S, et al:High survival in patients operated for small isolated liver metastases from gastric cancer:a multi-institutional study. World J Surg 38:2692-2697, 2014
23)Makino H, Kunisaki C, Izumisawa Y, et al:Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticancer Res 30:2367-2376, 2010
24)Miki Y, Fujitani K, Hirao M, et al:Significance of surgical treatment of liver metastases from gastric cancer. Anticancer Res 32:665-670, 2012
25)Oguro S, Imamura H, Yoshimoto J, et al:Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer. J Hepatobiliary Pancreat Sci 23:324-332, 2016
26)Ohkura Y, Shinohara H, Haruta S, et al:Hepatectomy offers superior survival compared with non-surgical treatment for</=3 metastatic tumors with diameters<3 cm from gastric cancer:a retrospective study. World J Surg 39:2757-2763, 2015
27)Oki E, Tokunaga S, Emi Y, et al:Surgical treatment of liver metastasis of gastric cancer:a retrospective multicenter cohort study(KSCC1302). Gastric Cancer 19:968-976, 2016
28)Shinohara T, Maeda Y, Hamada T, et al:Survival benefit of surgical treatment for liver metastases from gastric cancer. J Gastrointest Surg 19:1043-1051, 2015
29)Tatsubayashi T, Tanizawa Y, Miki Y, et al:Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer 20:387-393, 2017
30)Tsujimoto H, Ichikura T, Ono S, et al:Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406-413, 2010
31)Hirai I, Kimura W, Fuse A, et al:Surgical management for metastatic liver tumors. Hepatogastroenterology 53:757-763, 2006
32)Shirabe K, Shimada M, Matsumata T, et al:Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection:a multi-institutional study of the indications for resection. Hepatogastroenterology 50:1560-1563, 2003
33)Garancini M, Uggeri F, Degrate L, et al:Surgical treatment of liver metastases of gastric cancer:is local treatment in a systemic disease worthwhile? HPB(Oxford) 14:209-215, 2012
34)Schildberg CW, Croner R, Merkel S, et al:Outcome of operative therapy of hepatic metastatic stomach carcinoma:a retrospective analysis. World J Surg 36:872-878, 2012
35)Zacherl J, Zacherl M, Scheuba C, et al:Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6:682-689, 2022
36)Japanese Gastric Cancer Association:Japanese gastric cancer treatment guidelines 2021(6th edition). Gastric Cancer 26:1-25, 2023
37)Markar SR, Mackenzie H, Mikhail S, et al:Surgical resection of hepatic metastases from gastric cancer:outcomes from national series in England. Gastric Cancer 20:379-386, 2017
38)Kodera Y, Fujitani K, Fukushima N, et al:Surgical resection of hepatic metastasis from gastric cancer:a review and new recommendation in the Japanese gastric cancer treatment guidelines. Gastric Cancer 17:206-212, 2014
39)Kataoka K, Kinoshita T, Moehler M, et al:Current management of liver metastases from gastric cancer:what is common practice? New challenge of EORTC and JCOG. Gastric Cancer 20:904-912, 2017
40)Markar SR, Karthikesalingam A, Jackson D, et al:Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials:comparison between West and East. Ann Surg Oncol 20:2328-2338, 2013
41)Chang YC, Nagasue N, Abe S, et al:Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 87:321-325, 1992
42)Monroy DC, Ibañez-Pinilla M, Sabogal JC, et al:Survival outcomes of hepatectomy in gastric cancer liver metastasis:a systematic review and meta-analysis. J Clin Med 12:2023
43)Shirasu H, Tsushima T, Kawahira M, et al:Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric Cancer 21:338-344, 2018
44)Yoshida K, Yamaguchi K, Okumura N, et al:Is conversion therapy possible in stage IV gastric cancer:the proposal of new biological categories of classification. Gastric Cancer 19:329-338, 2016
45)Yamaguchi K, Yoshida K, Tanahashi T, et al:The long-term survival of stage Ⅳ gastric cancer patients with conversion therapy. Gastric Cancer 21:315-323, 2018
46)Yoshida K, Yasufuku I, Terashima M, et al:International retrospective cohort study of conversion therapy for stage IV gastric cancer 1(CONVO-GC-1). Ann Gastroenterol Surg 6:227-240, 2022
47)Takemura N, Saiura A, Ito H, et al:Proposal of new treatment algorithm for gastric cancer liver metastases:up-front surgery or conversion surgery? Glob Health Med 4:57-60, 2022
48)Smith GL, Banegas MP, Acquati C, et al:Navigating financial toxicity in patients with cancer:a multidisciplinary management approach. CA Cancer J Clin 72:437-453, 2022